Domain Structure of Human Nuclear DNA Helicase II (RNA Helicase A)*

(Received for publication, October 22, 1996, and in revised form, February 19, 1997)

Suisheng Zhang and Frank Grosse Dagger

From Abteilung Biochemie, Institut für Molekulare Biotechnologie, Postfach 100813, D-07708 Jena, Germany

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Full-length human nuclear DNA helicase II (NDH II) was cloned and overexpressed in a baculovirus-derived expression system. Recombinant NDH II unwound both DNA and RNA. Limited tryptic digestion produced active helicases with molecular masses of 130 and 100 kDa. The 130-kDa helicase missed a glycine-rich domain (RGG-box) at the carboxyl terminus, while the 100-kDa form missed both its double-stranded RNA binding domains (dsRBDs) at the amino terminus and its RGG-box. Hence, the dsRBDs and the RGG-box were dispensable for unwinding. On the other hand, the isolated DEXH core alone could neither hydrolyze ATP nor unwind nucleic acids. These enzymatic activities were not regained by fusing a complete COOH or NH2 terminus to the helicase core. Hence, an active helicase required part of the NH2 terminus, the DEXH core, and a C-terminal extension of the core. Both dsRBDs and the RGG-box were bacterially expressed as glutathione S-transferase fusion proteins. The two dsRBDs had a strong affinity to double-stranded RNA and cooperated upon RNA binding, while the RGG-box bound preferentially to single-stranded DNA. A model is suggested in which the flanking domains influence and regulate the unwinding properties of NDH II.


INTRODUCTION

Nuclear DNA helicase II (NDH II)1 was originally isolated from calf thymus by assaying its DNA unwinding activity (1). Subsequently, it was shown that NDH II also contains RNA helicase activity (2). The cDNA sequence of NDH II (3) revealed a high homology to two previously known proteins, namely human RNA helicase A (4) and the Drosophila "maleless" protein (MLE) (5). From the cDNA sequences it was also deduced that the three proteins belong to the superfamily of DEXH helicases, all members of which possess seven conserved helicase motifs in the putative catalytically active core. The presence of the DEXH helicase core domain suggests a function in RNA and/or DNA unwinding for all three members of this superfamily. The core contains an ATP binding site with the consensus sequence GCGKT (A site) and FILDD (B site) in motif I as well as a putative nucleic acid binding region QRKGRAGR in motif VI. In addition to the core, all three helicases have further nucleic acid binding motifs localized at either end of the molecule.

At the amino terminus there are two additional binding domains (dsRBD I and II) that might provide specificity for RNA (6). Similar motifs are conserved among a group of dsRNA-binding proteins, such as dsRNA-dependent protein kinase (DAI) (7), dsRNA-specific adenosine deaminase (DRADA) (8), Escherichia coli RNase III (9), the Drosophila staufen protein, the Xenopus laevis RNA-binding protein Xlrbpa, the human transactivator region binding protein (10, 11), and the vaccinia virus E3L protein (12). The carboxyl-terminal 100 amino acids of NDH II consist of a consecutive stretch of glycines that is regularly interrupted by either aromatic amino acids or arginine. Similar RGG-rich sequences (RGG-boxes) have been found as part of many nucleic acid-binding proteins, such as the heterogeneous nuclear ribonucleoproteins hnRNP A1 (13) and hnRNP U (14), nucleolin (15), yeast single-strand DNA-binding protein 1 (16), as well as of other proteins from the superfamily of DEX(D/H) helicases (17-23). Except hnRNP U, where the RGG-box is the only nucleic acid binding domain (14), RGG-boxes cooperate with other domains to achieve an increased affinity for nucleic acids.

Here, we have designed and produced various mutants of NDH II to delineate the modular structure of this enzyme with particular emphasis on the amino- and carboxyl-terminally localized nucleic acid binding domains. Our results confirm the importance of the dsRNA binding domains by showing that they influence both ATPase and helicase activities. Furthermore, the RGG-box at the COOH terminus enhances nucleic acid binding and may be required for an increased unwinding efficiency of the helicase core domain.


EXPERIMENTAL PROCEDURES

Cloning and Sequencing of the Gene Encoding Human NDH II

A Bluescript plasmid vector containing full-length cDNA of human NDH II was obtained from a lambda -Zap cDNA library of human T-cells primed with oligo(dT) or primed randomly (Stratagene). The library was screened with a cDNA probe for bovine NDH II (3) that was labeled with [alpha -32P]dCTP (Amersham Corp.). Hybridization was performed under conditions of low stringency (24). Subcloning and DNA sequencing was essentially as described earlier for bovine NDH II (3). The sequence data have been deposited at the GenBankTM/EMBL Data Bank under accession number Y10658[GenBank].

Baculovirus-mediated Overexpression of Human Nuclear DNA Helicase II and Its Derivatives

Full-length NDH II as well as several deletion mutants were constructed with bacmid vectors (Life Technologies, Inc.). For this, NH2- and COOH-terminal parts of the cDNA were amplified by PCR and then combined (see Fig. 9). The translation initiation codon ATG and the sequence information for six histidine residues were introduced into the NH2-terminal forward primers; the COOH-terminal reverse primers were provided with stop codons. PCR primers at both ends also contained a unique BamHI restriction site. The following PCR primers were used: F-1, starting at the initiating codon ATG (5'-CGTATCCAGCACCCATGGGCCATCATCATCATCATCATATGGGTGACGTTAAAAATTTTCTG-3'); F-2, corresponding to a start at amino acid residue (aa) 131 (5'-CGTATCCAGCACCCATGGGCCATCATCATCATCATCATGGCTATGGTGTTCCTGGG-3'); and F-3, corresponding to a start at aa 313 (5'- CGTATCCAGCACCCATGGGCCATCATCATCATCATCATGGCAAATTGGCTCAGTTC-3'). The three reverse primers for the COOH terminus were R-1, corresponding to a start at aa 952 (5'-CCTTAGTCGA); R-2, corresponding to a start at aa 1160 (5'-CCTTAGTCGATCAACGTGGACCATCTCCATA-3'); and R-3, starting from the natural stop codon TAA at codon 1270 (5'-CCTTAGTCGATCAATAGCCGCCACCTCCTCT-3'). The NH2-terminal PCR fragments were synthesized with primers F-1 and F-2 and a cDNA primer that was situated downstream from the unique restriction site HindIII at nucleotide position 770. The PCR product beginning with F-3 was built-up with another internal primer that bypassed the restriction site ScaI at nucleotide position 1575 (see Fig. 9). At the COOH terminus, the reverse primers R-1 and R-2 were combined with an upstream cDNA primer yielding PCR products that contained the SacI site at nucleotide position 2336. R-3 was used with another internal primer to pass the PstI site at nucleotide position 3193 (see Fig. 9). For subcloning, PCR products encoding the NH2 terminus could be digested with HindIII or ScaI, while PCR products encoding the COOH terminus could be cleaved by SacI or PstI. The NH2- and COOH-terminal PCR fragments were ligated to the central cDNA fragments bordered by HindIII and SacI (1566 bp), HindIII-PstI (2423 bp), ScaI-SacI (761 bp), and ScaI-PstI (1618 bp). All PCR products were digested with BamHI and ligated into the donor plasmid pFastBAC1 by using the BamHI restriction site downstream of the polyhedrin promotor. The directionality of the inserts was determined by PCR using the forward primer 5'-AAAATGATAACCATCTCGCAAA-3' and insert-specific internal primers for the retrograde strand. Recombinant bacmids were produced according to the instructions of the manufacturer (Life Technologies, Inc.). Recombinant bacmids were transfected into Sf9 insect cells in the presence of Cellfectin (Life Technologies, Inc.); supernatants from transfected cells were collected after 48-72 h. Virus stocks were prepared with a multiplicity of infection of 0.01-0.1.


Fig. 9. Expression of NDH II core-containing fragments with the baculovirus system. A, schematic representation of the expressed protein fragments. The restriction sites and the forward and reverse primers used for the generation of the corresponding fragments are also indicated (see "Experimental Procedures" for detail). B, the baculovirus-expressed proteins were eluted from Ni2+-NTA-agarose at 80 mM imidazole and then separated on an 8% SDS-polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane (Hybond-C) and subsequently incubated with a rabbit antiserum directed against human RNA helicase A at a 1:1000 dilution. The proteins were visualized by ECL.
[View Larger Version of this Image (19K GIF file)]


Expression and Purification of Recombinant Proteins

Baculovirus stocks from human NDH II vectors were used to infect 1-2.5 · 108 Sf9 cells in 10-25 culture dishes (140 mm in diameter) at a multiplicity of infection of 1-5. Cells were harvested 40-48 h postinfection and washed with ice-cold phosphate-buffered saline (10 mM sodium phosphate, pH 7.4, 140 mM NaCl, 3 mM KCl). Whole cell extracts were prepared at 4 °C by homogenizing the cells in 2 ml of hypotonic buffer A (25 mM HEPES-KOH, pH 7.9, 10 mM NaCl, 10 mM Na2S2O5, 5 mM MgCl2, 7 mM beta -mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride and 0.1% (v/v) Trasylol (Bayer-Leverkusen, Germany)) followed by a 30-min incubation with the same volume of high salt buffer B (25 mM HEPES-KOH, pH 7.9, 1 M NaCl, 10 mM Na2S2O5, 5 mM MgCl2, 1.6 mM imidazole, 7 mM beta -mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.1% Trasylol, and 30% glycerol). The extracts were centrifuged at 15,000 rpm for 15 min. The supernatants were carefully removed and mixed with 250-500 µl of Ni2+-NTA-agarose (Qiagen) under gentle agitation for 45 min. Recombinant proteins, which bound to the nickel column, were purified by centrifugation at 1500 × g for 3 min followed by a series of wash steps with 0.8, 5, 20, and 40 mM imidazole present in 5 ml of buffer C (25 mM HEPES-KOH, pH 7.9, 0.5 M NaCl, 10 mM Na2S2O5, 5 mM MgCl2, 7 mM beta -mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.1% Trasylol, and 15% glycerol). Proteins were eluted at 80 mM and at 300 mM imidazole with three bed volumes of buffer C. The imidazole-eluted fractions with a complete NH2 terminus (including full-length NDH II) were dialyzed overnight at 4 °C against buffer D (20 mM HEPES-KOH, pH 7.9, 50 mM NaCl, 10 mM Na2S2O5, 7 mM beta -mercaptoethanol, 10% glycerol) and then loaded onto poly(rI·rC)-agarose (500 µl) preequilibrated with buffer D. The columns were washed with 1.5 ml of buffer D, and the proteins were eluted by increasing the NaCl concentration stepwise with 100 mM increments from 0.1 to M and a subsequent wash with 2 M NaCl in buffer D. NDH II constructs containing a complete NH2 terminus eluted between 0.6 and 2 M NaCl. These fractions were combined, dialyzed against buffer E (20 mM HEPES-KOH, pH 7.9, 10 mM Na2S2O5, 7 mM beta -mercaptoethanol), concentrated, and stored at -70 °C in the presence of 50% glycerol.

The fragment containing the DEXH core domain alone was purified on Ni2+-NTA-agarose. For further purification this protein was dialyzed against buffer D at 4 °C; then it was applied to 250 µl of phosphocellulose P-11 (Whatman) equilibrated with buffer D. The protein in the flow-through was dialyzed against buffer C (25 mM HEPES-KOH, pH 7.9, 0.5 M NaCl, 10 mM Na2S2O5, 5 mM MgCl2, 7 mM beta -mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.1% Trasylol, and 15% glycerol) and loaded onto a second Ni2+-NTA-agarose column (250 µl). Loading was repeated three times, and then the protein was eluted with 300 mM imidazole in buffer C. Protein of the second nickel column was dialyzed against buffer E containing 50% glycerol and stored at -70 °C.

E. coli-mediated Overexpression of Fragments of Nuclear DNA Helicase II

Amino- and carboxyl-terminal domains of human NDH II were expressed in E. coli as GST fusion proteins (see Figs. 7A and 8A) by using pGEX-2T as plasmid vector (Pharmacia Biotech Inc.). The corresponding gene fragments were synthesized by PCR from a cDNA encoding full-length human NDH II. The following primers were used: 5'-CGTATCCAGCATGGGTGACGTTAAAAATTTTCTG-3' (sense) and 5'-CTTAGGATCTAGAGGCCCCTACCTCAGAATTATT-3' (antisense) for aa 1-130, corresponding to dsRBD I; 5'-CGTATCCAGCATGGGTGACGTTAAAAATTTTCTG-3' (sense) and 5'-CTTAGGATCTGAACTGAGCCAATTTGCC-3' (antisense) for aa 1-318, corresponding to dsRBD I and II; 5'-CGTATCCAGCGGCTATGGTGTTCCTGGG-3' (sense) and 5'-CTTAGGATCTGAACTGAGCCAATTTGCC-3' (antisense) for aa 131-318, corresponding to dsRBD II; 5'-CGTATCCAGCACCTGGGAAGCCAAAGTTCAG-3' (sense) and 5'-CTTAGGATCTACGTGGACCATCTCCATA-3' (antisense) for aa 953-1160, corresponding to the carboxyl-terminal extension of the DEXH core; 5'-CGTATCCAGCACCTGGGAAGCCAAAGTTCAG-3' (sense) and 5'-CTTAGGATCTATAGCCGCCACCTCCTCT-3' (antisense) for aa 953-1269, corresponding to the DEXH core extension plus the RGG-box; and finally 5'-CGTATCCAGCCCTCCCAAGATGGCCCGA-3' (sense), and 5'-CTTAGGATCTATAGCCGCCACCTCCTCT-3' (antisense) for aa 1161-1269, corresponding to the RGG-box alone.


Fig. 7. Nucleic acid binding of the dsRBD domains of human NDH II. A, schematic representation of the expressed protein fragments. B, the corresponding fragments of NDH II were expressed as GST fusion proteins and purified as described under "Experimental Procedures." For each experiment, 250-500 µg of protein were chromatographed on 250 µl of poly(rI·rC)-agarose and analyzed by electrophoresis through a 10% SDS-polyacrylamide gel and subsequent Coomassie staining.
[View Larger Version of this Image (62K GIF file)]



Fig. 8. Nucleic acid binding of the carboxyl-terminal domains of human NDH II. A, schematic representation of the expressed protein fragments. B, 5 µl of bacterial crude extract were prepared by suspending the bacterial pellet from 2 ml of LB culture in 500 µl of SDS-PAGE sample buffer. The suspension was sonicated, treated at 95 °C for 5 min, and then loaded onto a 10% SDS-polyacrylamide gel. The lanes were loaded as indicated, starting (from left to right) with GST-C953-1160, followed by GST-C953-1269, followed by GST-C1161-1269, i.e. the RGG-box alone. After electrophoresis, the proteins were transferred onto a Hybond C nitrocellulose membrane and stained with Ponceau S (left panel) or probed with either 5'-32P-labeled poly(rI·rC) (center) or 5'-32P-labeled poly(rI) (right).
[View Larger Version of this Image (41K GIF file)]


All sense primers contained a BamHI restriction site, and the antisense primers contained an EcoRI restriction site, both underlined. The PCR products were digested with BamHI and EcoRI, gel-purified, and ligated with the correspondingly treated pGEX-2T vector. Recombinant pGEX-2T plasmids were transformed into the E. coli strain TG-1; the plasmid inserts were sequenced.

Expression and Purification of GST Fusion Proteins

Transfected E. coli TG-1 bacteria were grown in 200 ml of LB culture in the presence of 50 µg/ml ampicillin to an A600 value of 0.6-0.8. The expression of recombinant proteins was induced by adding 0.5 mM isopropyl-1-thio-beta -D-galactopyranoside. Three hours after induction, the bacteria were collected by centrifugation, resuspended in 1 ml of phosphate-buffered saline, and finally lysed by sonication on ice. The lysate was centrifuged at 15,000 rpm for 10 min, and the supernatant was mixed with a 1-ml bed volume of glutathione Sepharose 4B (Pharmacia) that had been preequilibrated with phosphate-buffered saline. GST fusion proteins were batch-purified according to the instructions of the manufacturer. Purified fusion proteins were stored at -70 °C.

Northwestern Blot Assay

Northwestern blot assays were performed as described (11). Bacterial lysates from each mutant protein were prepared by suspending bacteria from 2 ml of LB medium into 500 µl of SDS-PAGE loading buffer followed by sonication. Five-µl fractions of the supernatants were electrophoresed through a 10% SDS-polyacrylamide gel and electrotransferred to a Hybond-C nitrocellulose membrane (Amersham). The membrane was incubated with 8 M urea in Tris-buffered saline (25 mM Tris, 140 mM NaCl, and 3 mM KCl). To achieve protein renaturation, there followed 10 steps of 2:3 dilutions with Tris-buffered saline. Nonspecific binding sites were blocked by treating the membrane with 5% (w/v) milk powder in probing buffer (25 mM NaCl, 10 mM MgCl2, 10 mM HEPES, pH 8.0, 0.1 mM EDTA, 1 mM dithiothreitol) for 1 h at room temperature. Then one of the 32P-labeled RNA probes, poly(rI·rC), poly(rI), or poly(rC) (Pharmacia), was added in probing buffer. The membrane was incubated for another 30 min at room temperature. Washes were performed by three changes of probing buffer within 15 min. The membranes were exposed to x-ray film overnight at -80 °C.

Nucleic Acid Matrix Binding Assay

About 250-500 µg of human NDH II-derived NH2- and COOH-terminal GST fusion products were purified by chromatography on glutathione-Sepharose 4B and then loaded onto 250 µl of either poly(rI·rC)-agarose or ssDNA-agarose (Pharmacia). The columns were equilibrated with binding buffer containing HEPES-KOH, pH 7.9, 50 mM NaCl, 1 mM dithiothreitol, and 1 mM EDTA. The columns were washed with 0.75 ml of binding buffer and then eluted with 100 mM, 200 mM, 300 mM, 500 mM, 1 M, and 2 M NaCl in binding buffer. 500-µl fractions were taken at each NaCl concentration, and 25 µl thereof were further processed for 10% SDS-PAGE. After electrophoresis, the proteins were visualized by staining with Coomassie Brilliant Blue. Alternatively, 0.5-10 µl of the baculovirus-expressed proteins were purified on Ni2+-NTA-agarose and mixed with 30 µl of either poly(rI·rC)-agarose or ssDNA-agarose that was preequilibrated with 50 mM, 100 mM, 200 mM, 300 mM, 500 mM, and 1 M NaCl in binding buffer. After incubation for 30 min at room temperature, the agarose beads were spun down at 15,000 rpm for 5 min, washed extensively with 20-25 bed volumes of binding buffer with the corresponding NaCl concentration, and finally resuspended in 30 µl of SDS-PAGE sample buffer for protein elution. Ten µl of each of the supernatant fractions were heated to 95 °C for 3 min, centrifuged, and then electrophoresed through an 8% SDS-polyacrylamide gel. After transfer to a Hybond-C nitrocellulose membrane, proteins were detected with a 1:1000 dilution of rabbit antiserum against human RNA helicase A in an enhanced chemoluminescence procedure (ECL, Amersham).

Trypsin Digestion of Human NDH II

Recombinant full-length human NDH II (500 ng) was digested with trypsin at a weight ratio of trypsin to NDH II of 1:5, 1:50, and 1:500, respectively, in 10 µl of 20 mM HEPES-KOH, pH 7.9, 50 mM NaCl, 5 mM MgCl2, and 1 mM dithiothreitol. Digestions were performed at 37 °C for 30 and 60 min. Then the digestion mixtures were mixed with 5 µl of SDS-PAGE sample buffer and heated to 95 °C for 5 min. Tryptic products were analyzed by electrophoresis on an 8% SDS-polyacrylamide gel.

Other Methods

Preparation of RNA helicase and DNA helicase substrates as well as enzyme assays for nucleic acid-dependent NTPase activity, RNA helicase activity, and DNA helicase activity were performed as described (2).


RESULTS

Cloning and Expression of Human NDH II

Nuclear DNA helicase II was previously isolated from bovine tissue according to its DNA unwinding property and later shown to unwind RNA as well (1, 2). Molecular cloning of the NDH II-encoding gene revealed a high homology to human RNA helicase A (3, 4), which was described to unwind only RNA but not DNA (25). To redetermine the substrate specificity of human NDH II, the gene was cloned. This independently cloned cDNA sequence was very similar to the recently modified sequence of human RNA helicase A (PIR accession number Q08211[GenBank]), with the exception of two missense exchanges (Q970E and K1036N) and a slightly altered COOH terminus (Fig. 1).


Fig. 1. Carboxyl-terminal amino acid sequences of human RNA helicase A (top) and human NDH II (bottom). Differences between the sequences are underlined.
[View Larger Version of this Image (7K GIF file)]


Human NDH II Unwinds both DNA and RNA

The cDNA of human NDH II was provided with the sequence information for six NH2-terminal histidine residues and expressed in insect cells by using a baculovirus-based expression system. Recombinant NDH II was purified on a Ni2+-NTA-agarose column and subsequent chromatography on poly(rI·rC) agarose. The purified enzyme had the expected molecular mass of 140 kDa, i.e. it was clearly bigger than the previously isolated forms of bovine NDH II (Fig. 2). As its bovine homologue, the recombinant human enzyme unwound both dsRNA and double-stranded DNA in an ATP-dependent manner (Fig. 3).


Fig. 2. Limited proteolysis of recombinant human NDH II. Each lane contained about 400 ng of NDH II. Protein samples were separated on an 8% SDS-polyacrylamide gel and visualized by staining with Coomassie Brilliant Blue. Lanes 1 and 2 contained bovine NDH II in its 100- and 130-kDa forms, respectively, and lane 3 contained recombinant human NDH II. Tryptic digestion of human NDH II was performed at the indicated ratios of trypsin to NDH II and the indicated incubation times (lanes 4-11). Lane 12 contained a molecular weight standard.
[View Larger Version of this Image (81K GIF file)]



Fig. 3. RNA and DNA unwinding catalyzed by recombinant human NDH II. RNA and DNA helicase assays were performed as described (2). RNA unwinding (left) was measured with a substrate consisting of two RNA strands of 194 and 130 nucleotides in length that contained a duplex region comprising 17 bp. The substrate for DNA unwinding (right) was M13mp18 ssDNA with a hybridized primer (22 bp) that had a 23-nucleotide-long unhybridized tail at the 3'-end (2). The amount of enzyme and the presence or absence of 3 mM ATP are indicated; the molar ratios of enzyme over substrate were 10:1 for DNA unwinding and 1:1 for RNA unwinding.
[View Larger Version of this Image (46K GIF file)]


Limited Proteolysis of Human NDH II

Bovine NDH II preparations usually consisted of two distinct protein bands with apparent molecular masses of 130 and 100 kDa that were active in both DNA and RNA unwinding (1, 2). To define a smaller form of the protein that still contains its unwinding activity, we attempted to digest recombinant NDH II in a controlled manner. A digestion pattern comparable with that of bovine NDH II could be produced by limited tryptic digestion. When the weight ratio of trypsin to NDH II was adjusted to 1:500, only the 130-kDa form of the enzyme was generated (Fig. 2, lanes 6 and 7), while a ratio of 1:50 produced both the 130- and the 100-kDa forms of the protein (Fig. 2, lanes 8 and 9). Proteolyzed human NDH II bound to poly(rI·rC), comparable with the bovine homologue, with the 100-kDa form eluting at 0.2-0.3 M NaCl and the 130-kDa form eluting at about 0.5 M NaCl (Fig. 4). These differences in the chromatographic behavior allowed a separation of the tryptic digestion products from each other. Both tryptic forms of human NDH II were active in DNA and RNA unwinding (data not shown).


Fig. 4. Poly(rI·rC)-agarose chromatography of the tryptic products of human NDH II. Recombinant human NDH II was purified by Ni2+-NTA-agarose chromatography and treated with a 1:50 mass ratio of trypsin to NDH II for 60 min. The digestion products were loaded onto a poly(rI·rC)-agarose column and eluted by increasing concentrations of NaCl. The eluted protein fractions were separated on an 8% SDS-polyacrylamide gel.
[View Larger Version of this Image (89K GIF file)]


The course of digestion was further analyzed by probing the products with an anti-histidine antibody that specifically recognized the NH2 terminus. The 130-kDa form reacted well with anti-histidine antibody (Fig. 5), indicating that it contained an intact amino terminus. Therefore, it is reasonable to conclude that the carboxyl-terminal amino acids representing the RGG-box were removed first. In contrast, the 100-kDa product did not react with this antibody, revealing the deletion of at least the NH2-terminal histidine tag. At most, 30 kDa (~270 amino acids) might have been removed from the NH2 terminus as the second tryptic cutting event. This region would contain both dsRBDs that have been attributed to the amino acid residues 3-72 and 180-253, respectively (Fig. 7) (6). It was surprising that full-length NDH II reacted more weakly with the anti-histidine antibody than the COOH-terminally deleted form (Fig. 5).


Fig. 5. Analysis of the tryptic products of human NDH II by using a monoclonal antibody directed to the NH2-terminal histidine tag. Recombinant human NDH II was treated with trypsin at a mass ratio of 50:1 for 60 min. The digestion products were separated on an 8% SDS-polyacrylamide gel and subsequently blotted onto a Hybond-C nitrocellulose membrane. Then the nitrocellulose was probed with a monoclonal antibody recognizing the histidine tag (Qiagen). The left lane represents highly purified NDH II; the bands at 130 and about 80 kDa were not visible by Coomassie staining of a corresponding SDS gel. The right lane represents the digestion products; here a predominant band at 100 kDa was clearly visible by Coomassie staining (data not shown).
[View Larger Version of this Image (23K GIF file)]


A more quantitative treatment of the influence of COOH- and NH2-terminal deletions on the unwinding properties of NDH II was difficult to accomplish, mainly because minor differences in nucleic acid unwinding were hard to quantify. Therefore, the nucleic acid-dependent ATPase activity was taken as an indicator for the unwinding activity of NDH II. The ATPase activities of the 130- and 100-kDa forms were stimulated by poly(rI·rC) and by ssDNA (Fig. 6). With these effectors, the turnover rate of ATP hydrolysis was about 1.5-2-fold higher for the 100-kDa tryptic product than for the 130-kDa form (Fig. 6). Hence, once the RGG-box has been removed, the subsequent removal of parts of the NH2 terminus stimulated ATP hydrolysis.


Fig. 6. Nucleic acid-dependent ATPase activities of human NDH II and NDH II-derived protein fragments. A, NDH II and protein fragments thereof were first purified by chromatography on Ni2+-NTA-agarose followed by purification on poly(rI·rC)-agarose. Lanes 1 and 2, full-length NDH II after Ni2+-NTA- and poly(rI·rC)-agarose, respectively; lanes 3 and 4, the fragment consisting of dsRBD I and II plus DEXH core after Ni2+-NTA- and poly(rI·rC)-agarose, respectively; lanes 5 and 6, the DEXH core alone after Ni2+-NTA- and a second Ni2+-NTA-agarose purification, respectively; lane 7, the DEXH core with its amino-terminal extension including the RGG-box. This fragment was not further purified on poly(rI·rC)-agarose because of severe losses during this step. The arrow on the right side indicates the protein band that, in a separate experiment, cross-reacted with antibodies directed against RNA helicase A. Purified recombinant proteins were separated on an 8% SDS-polyacrylamide gel and visualized by staining with silver. B, 300 ng (each) of the most purified fractions were used for measuring the ATPase activities in the presence of poly(rI·rC), MS-2 phage ssRNA, and M13mp18 ssDNA (50 µg/ml each).
[View Larger Version of this Image (27K GIF file)]


The Isolated dsRBD Domains of Human NDH II Bind Preferentially to dsRNA

To study the relative contribution of either of the potential dsRNA binding domains at the amino terminus to nucleic acid binding, dsRBDs I and II were expressed in E. coli as three GST fusion proteins comprising the amino acid residues 1-130 (dsRBD I), 131-318 (dsRBD II), and 1-318 (dsRBD I + II) (Fig. 7A). The RNA binding abilities of all three polypeptides were determined by chromatography on a poly(rI·rC)-agarose column. All three constructs bound well to the dsRNA column. GST-dsRBD I and dsRBD II began to elute at 0.5 M NaCl, while the elution of the construct with both dsRBDs started at 1 M NaCl (Fig. 7B). All three constructs bound also to a single-stranded DNA cellulose column, where GST-dsRBD I and GST-dsRBD II became eluted between 0.2 and 0.3 M NaCl, whereas the GST-dsRBD I + II construct came off between 0.3 and 1 M (data not shown). The higher salt resistance of binding of dsRBD I + II in comparison to dsRBD I and dsRBD II suggests a cooperation of the two domains for nucleic acid binding. A cooperation was also deduced from Northwestern blot experiments, where the individual domains gave much weaker binding signals with poly(rI)·(rC) than the construct having both domains present (data not shown).

The RGG-box of NDH II Binds Preferentially to Single-stranded Nucleic Acids

To study the nucleic acid binding properties of the carboxyl terminus, three C-terminal fragments of NDH II were expressed as GST fusion proteins (Fig. 8A). Binding of these fusion products to dsRNA and ssRNA was analyzed by Northwestern assays. Both RGG-box-containing fusion proteins bound to poly(rI) and poly(rI·rC), while the fragment comprising aa 953-1160 (without an RGG-box) did not display binding to either nucleic acid (Fig. 8B). The RGG-box-containing fusion proteins were eluted with 50-100 mM salt from a poly(rI·rC)-agarose column (data not shown). Hence, this type of binding was highly salt-sensitive and may have been caused by electrostatic interactions. In striking contrast, the RGG-box-containing fragments bound strongly to ssDNA-agarose, even in the presence of 1-2 M NaCl (data not shown).

Baculovirus Expression of Truncated Forms of NDH II

Full-length human NDH II comprising aa 1-1269 as well as the truncated fragments shown in Fig. 9A were all expressed in insect cells by using recombinant baculoviruses. Each of the recombinant proteins carried an N-terminal histidine tag to allow an easy purification on nickel columns. The yield of the purified proteins varied considerably between the different recombinants, most likely because some of the proteins were rapidly degraded. All recombinant proteins were analyzed by Western blotting with serum against human RNA helicase A. The observed molecular weights were in accordance with the calculated ones (Fig. 9B).

The nucleic acid binding affinities of the recombinant proteins, were probed by binding to poly(rI·rC)-agarose (Fig. 10). Full-length NDH II (data not shown) as well as the DEXH helicase core domain (aa 313-952) bound dsRNA even in the presence of 1 M NaCl (Fig. 10, left). Comparable binding was observed when the complete NH2 terminus was fused to the core domain (Fig. 10, middle). However, when only the dsRBD II domain was fused to the core, a reduced binding to dsRNA resulted (Fig. 10, right). Binding could not be further increased when the amino acids 953-1160 were fused to the dsRBD II-core construct (data not shown). All these constructs bound comparably well to ssDNA-cellulose. While the RGG-box hardly had an influence on RNA binding, binding to ssDNA was best with all constructs that contained an RGG-box (data not shown).


Fig. 10. Salt-dependent binding of NDH II core-containing fragments to poly(rI·rC)-agarose. Purified proteins were bound to poly(rI·rC)-agarose in the presence of 50 mM to 1 M NaCl as specified. Then the affinity matrix was extensively washed with the same concentration of NaCl that had been used for loading. Proteins were eluted with 30 µl of SDS-PAGE sample buffer and separated on a 10% SDS-polyacrylamide gel. After electrophoresis, proteins were transferred onto nitrocellulose and analyzed with a polyclonal antiserum against human RNA helicase A. The right lanes contained a sample of the loaded protein, specified as (L). The left panel displays the binding properties of the DEXH core, the middle panel shows binding of the fragment consisting of dsRBD I + II plus core, and the right panel shows binding of the core fused to dsRBD II alone.
[View Larger Version of this Image (43K GIF file)]


ATPase and Helicase Activities of NDH II-derived Fragments

Baculovirus-expressed NDH II as well as the NDH II fragments consisting of aa 1-952, 313-952, and 313-1269, were purified on nickel-agarose and poly(rI·rC)-agarose (Fig. 6A). With these proteins as well as the tryptic products, shown in Fig. 4, ATPase assays were performed in the presence of poly(rI·rC), MS-2 phage ssRNA, and M13mp18 ssDNA (Fig. 6B). The ATPase activity of full-length NDH II was most stimulated by poly(rI·rC), followed by ssRNA from the bacteriophage MS2, followed by ssDNA from the bacteriophage M13. Furthermore, both tryptic products, p100 and p130, displayed nucleic acid-dependent ATPase activities, which however seemed to be less well stimulated by MS-2 RNA. In contrast, the amino-terminal part of NDH II, including the DEXH core, and the DEXH core alone were devoid of nucleic acid-stimulated ATPase activity, although all these constructs were able to bind RNA and DNA and all contained a Walker-type ATP binding site. In agreement with the failure to observe nucleic acid-stimulated ATPase activity, neither of the truncated products could unwind RNA or DNA (data not shown).


DISCUSSION

Nuclear DNA helicase II was originally purified and characterized as an ATP-dependent DNA helicase and subsequently shown to unwind both DNA and RNA (1, 2). Sequencing of the NDH II-encoding gene revealed a high homology to two previously known proteins, namely human RNA helicase A and the Drosophila MLE protein (3). RNA helicase A has been characterized as an RNA helicase only with no propensity to unwind DNA (25). Because of the high homology between RNA helicase A and NDH II (96% identity, 92% similarity), the apparent different substrate specificity of both enzymes was surprising. To solve this discrepancy, we independently cloned the gene of human NDH II/RNA helicase A and overexpressed it to measure its substrate specificity. The human NDH II gene obtained in this screening showed two nucleotide exchanges to the previously published (and recently corrected) primary sequence of human RNA helicase A (accession number Q08211[GenBank]) in addition to a different COOH terminus (see Fig. 1). Expression of the human NDH II clone in baculovirus-infected insect cells and subsequent purification yielded sufficient amounts of NDH II to redetermine its substrate specificity. It turned out that human NDH II, like its bovine homologue, unwound both DNA and RNA. In theory, the different COOH termini of both molecular clones may explain the different substrate specificities for NDH II and RNA helicase A. This, however, is unlikely, since the COOH terminus is dispensable for unwinding of either nucleic acid (see below).

Both NDH II and MLE belong to the superfamily of DNA/RNA helicases displaying a DEX(D/H) helicase motif in the core domain (26-29). For all helicases, it is believed that nucleic acid binding plays a critical role in coordinating NTP hydrolysis and the unwinding process (30). Nucleic acid binding has been attributed to the seven conserved ATPase/helicase motifs. Experimental evidence for this came from studies on the eukaryotic translation initiation factor 4A as well as the CI protein from plum pox virus. For these two proteins, the nucleic acid binding domain has been assigned to the amino acid consensus sequence (H/Q)RIGRXXR present in motif VI (31, 32). Alternatively, nucleic acid binding may involve all seven regions of the DEX(D/H) core (33). In any case, binding of the seven conserved DEX(D/H) motifs to nucleic acid seems to determine both affinity and specificity, conferring either RNA or DNA unwinding, to the members of this protein family.

In addition to the central core motif, many DEX(D/H) proteins contain further nucleic acid binding domains, such as the arginine-serine (RS)-rich domain of two other human RNA helicases (34, 35), a motif for binding to ribosomal RNA of yeast PRP22 (36), and finally a glycine-rich motif, called RGG-box (17-23). NDH II contains, in addition to the DEIH core, two copies of a dsRNA binding domain at its NH2 terminus (6) and an RGG-box at its COOH terminus. We have examined the contributions of these motifs to the enzymatic mechanism of NDH II.

Neither the (proteolytic) deletion of the RGG-box nor the deletion of the two dsRBDs abolished the unwinding activity. Rather, the 100-kDa form of NDH II could act as ATP-driven nucleic acid helicase for both DNA and RNA. On the other hand, the overexpressed and purified helicase core (aa 313-952, 72 kDa) as well as genetically engineered and purified NDH II fragments consisting of aa 1-952 (107 kDa) and 313-1269 (105 kDa) had no detectable ATPase or helicase activity. Further attempts to confine the amino acid sequence to a shorter but still active "minihelicase" have been unsuccessful so far. Proteolytic degradation was no longer controllable when NDH II became smaller than the 100-kDa fragment; genetic constructs with various NH2- and COOH-terminal extensions of the (stable) core were highly unstable when expressed in insect cells. Although not definitely proven, from the sum of our data we can deduce that a minimal helicase most likely consists of aa 313-1160 (95 kDa).

Although dispensable for the basic enzymatic properties of DNA and RNA unwinding, the very COOH and NH2 termini of NDH II are phylogenetically conserved and also present in the MLE protein of Drosophila. Therefore, the properties of the NH2- and COOH-terminal domains were analyzed in a more detailed way. Northwestern assays and chromatography on poly(rI·rC)-agarose demonstrated dsRNA binding for the isolated dsRBDs. For efficient binding to dsRNA, both dsRBDs were necessary. Furthermore, dsRBD-containing fragments bound poly(rI·rC) in the presence of up to 0.5 M NaCl. In this respect, the dsRBDs from human NDH II were comparable with other dsRBDs, such as those of the dsRNA-dependent protein kinase DAI (7), the dsRNA-specific adenosine deaminase DRADA (37), and the E3L protein from vaccinia viruses (12, 38). For DAI it has been shown that its two N-terminal dsRBDs are responsible for specific binding to dsRNA. In this case, binding to dsRNA induces a conformational change, which in turn activates the catalytic domain of DAI (7). In the case of DRADA, the deletion of one of its three dsRBDs did not affect RNA binding but abolished the catalytic function of the deaminase domain (8). By analogy, the two dsRBDs of NDH II may have regulatory functions in the unwinding activity (see below) rather than direct effects on nucleic acid binding.

The RGG domain mediated binding to ssRNA and ssDNA as revealed by Northwestern assays and nucleic acid affinity chromatography. A preferred affinity for single-stranded nucleic acids has also been found for the RGG domains from hnRNP A1 (13), hnRNP U (14), and nucleolin (15). The RGG-box of nucleolin displays a beta -spiral structure that binds single-stranded nucleic acids with an induced base unstacking effect (39), most likely with the consequence of duplex unwinding (40). In the case of hnRNP U, the RGG domain is the only nucleic acid binding domain; nevertheless, it mediates binding to ssDNA even in the presence at 0.5-1 M NaCl (14). Such a high affinity for ssDNA may be a prerequisite for the observed binding of hnRNP U to nuclear matrix elements (SAR/MAR) (41, 42); it may also help to unwind SAR/MAR elements (43). Similar to hnRNP U, the RGG-box of human NDH II bound to ssDNA-agarose at salt concentrations of more than 0.5 M NaCl. However, we did not observe unwinding or destabilization of double-stranded DNAs or RNAs by the sole action of the individually expressed RGG domain from NDH II (data not shown).

All three additional nucleic acid binding domains might be neighbors in the three-dimensional structure of NDH II (Fig. 11). This suggestion arose from combining the results of the limited proteolysis experiments and monoclonal antibody studies for detecting the histidine-tagged NH2 terminus. The removal of the RGG-box from the COOH terminus apparently enhanced binding of the anti-histidine antibody to the NH2 terminus, suggesting a close neighborhood between the RGG-box and the dsRBDs. The proteolytic removal of the RGG-box diminished the nucleic acid-stimulated ATPase activity of NDH II. This, however, could be partially regained by further deleting the dsRBDs. A cooperation between the RGG domain and the dsRBDs may be the first step to recognize a single-stranded/double-stranded junction. An initial protein-nucleic acid contact with the RGG domain and the dsRBDs then might trigger the activation of the ATPase/helicase activity, analogously to the allosteric activation effects observed with DRADA (8) and with DAI (7). Further experiments on possible cooperative effects during nucleic acid unwinding, involving both full-length NDH II and the 100-kDa form, are necessary to further substantiate this speculation.


Fig. 11. A model for the spatial arrangements of the nucleic acid binding domains of human nuclear DNA helicase II (RNA helicase A).
[View Larger Version of this Image (19K GIF file)]


The molecular dissection of the domain structure of NDH II resulted in a rather complex picture of its enzymatic function(s); a highly conserved but dispensable COOH terminus mediates binding to single-stranded nucleic acids, particularly DNA, while the also dispensable NH2 terminus brings about binding or recognition of double-stranded nucleic acids, particularly RNA. Analogous to DRADA and DAI, this type of recognition might regulate the ATP-driven unwinding activity localized in the center of the molecule. The supposed control mechanism for the enzymatic activity of NDH II, the phylogenetically conserved structure of the corresponding domains from Diptera to mammals, the relative abundance of NDH II in the nuclei of all tissues studied so far, and its propensity to unwind DNA and RNA may give some hints about its physiological function. A nuclear helicase that unwinds any nucleic acid might be particularly suited for melting out DNA:RNA hybrids, such as those occurring during transcription and thereby help to remove the nascent transcript from the DNA strand. During this process, single-stranded DNA of the open complex might be first recognized by the RGG domain, while one or both of the dsRBDs dock onto the RNA:DNA hybrid. This might switch on the ATPase/unwinding activity of the helicase core domain, which in turn is a prerequisite for melting out the DNA:RNA duplex structure. Certainly, further experiments are required to further substantiate our current point of view.


FOOTNOTES

*   This work was supported by Deutsche Forschungsgemeinschaft Grant Gr 895/5-2.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) Y10658[GenBank].


Dagger    To whom correspondence should be addressed. Tel.: 49-3641-656291; Fax: 49-3641-656288; E-mail: fgrosse{at}imb-jena.de.
1   The abbreviations used are: NDH II, human nuclear DNA helicase II; hnRNP, heterogeneous nuclear ribonucleoprotein; PCR, polymerase chain reaction; aa, amino acid(s); bp, base pair(s); NTA, nitrolotriacetic acid; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; ssDNA, single-stranded DNA; ssRNA, single-stranded RNA; dsDNA, double-stranded DNA; dsRBD, double-stranded RNA binding domain.

ACKNOWLEDGEMENTS

We thank Dr. E. Birch-Hirschfeld for synthesizing all the oligonucleotides and A. Schneider for technical help. Rabbit antiserum against human RNA helicase A was generously supplied by Prof. Dr. J. Hurwitz (Sloan-Kettering Institute, New York). We are grateful to Dr. R. Smith and C. Utermann-Kessler for editing the manuscript.


REFERENCES

  1. Zhang, S., and Grosse, F. (1991) J. Biol. Chem. 266, 20483-20490 [Abstract/Free Full Text]
  2. Zhang, S., and Grosse, F. (1994) Biochemistry 33, 3906-3912 [Medline] [Order article via Infotrieve]
  3. Zhang, S., Maacke, H., and Grosse, F. (1995) J. Biol. Chem. 270, 16422-16427 [Abstract/Free Full Text]
  4. Lee, C.-G., and Hurwitz, J. (1993) J. Biol. Chem. 268, 16822-16830 [Abstract/Free Full Text]
  5. Kuroda, M. I., Kernan, M. J., Kreber, R., Ganetzky, B., and Baker, B. S. (1991) Cell 66, 935-947 [Medline] [Order article via Infotrieve]
  6. Gibson, T. J., and Thompson, J. D. (1994) Nucleic Acids Res. 22, 2552-2556 [Abstract]
  7. Patel, R. C., and Sen, G. C. (1992) J. Biol. Chem. 267, 7671-7676 [Abstract/Free Full Text]
  8. Lai, F., Drakas, R., and Nishikura, K. (1995) J. Biol. Chem. 270, 17098-17105 [Abstract/Free Full Text]
  9. Kharrat, A., Macias, M. J., Gibson, T. J., Nilges, M., and Pastore, A. (1995) EMBO J. 14, 3572-3584 [Abstract]
  10. Bycroft, M., Grünert, S., Murzin, A. G., Proctor, M., and Johnston, D. S. (1995) EMBO J. 14, 3563-3571 [Abstract]
  11. St. Johnston, D., Brown, N. H., Gall, J. G., and Jantsch, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10979-10983 [Abstract]
  12. Chang, H. W., and Jacobs, B. L. (1993) Virology 194, 537-547 [CrossRef][Medline] [Order article via Infotrieve]
  13. Cobianchi, F., SenGupta, D. N., Zmudzka, B. Z., and Wilson, S. H. (1986) J. Biol. Chem. 261, 3536-3543 [Abstract/Free Full Text]
  14. Kiledjian, M., and Dreyfuss, G. (1992) EMBO J. 11, 2655-2664 [Abstract]
  15. Srivastava, M., Fleming, P. J., Pollard, H. B., and Burns, A. L. (1989) FEBS Lett. 250, 99-105 [CrossRef][Medline] [Order article via Infotrieve]
  16. Jong, A. Y.-S., Clark, M. W., Gilbert, M., Oehm, A., and Campbell, J. L. (1987) Mol. Cell. Biol. 7, 2947-2955 [Medline] [Order article via Infotrieve]
  17. Gururajan, R., Perry-O'Keefe, H., Melton, D. A., and Weeks, D. L. (1991) Nature 349, 717-719 [CrossRef][Medline] [Order article via Infotrieve]
  18. Iggo, R. D., Jamieson, D. J., MacNeill, S. A., Southgate, J., McPheat, J., and Lane, D. P. (1991) Mol. Cell. Biol. 11, 1326-1333 [Medline] [Order article via Infotrieve]
  19. Leroy, P., Alzari, P., Sassoon, D., Wolgemuth, D., and Fellous, M. (1989) Cell 57, 549-559 [Medline] [Order article via Infotrieve]
  20. Lasko, P. F., and Ashburner, M. (1988) Nature 335, 611-617 [CrossRef][Medline] [Order article via Infotrieve]
  21. Dorer, D. R., Christensen, A. C., and Johnson, D. H. (1990) Nucleic Acids Res. 18, 5489-5494 [Abstract]
  22. Jamieson, D. J., Rahe, B., Pringle, J., and Beggs, J. D. (1991) Nature 349, 715-717 [CrossRef][Medline] [Order article via Infotrieve]
  23. Roussell, D. L., and Bennett, K. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9300-9304 [Abstract]
  24. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, p. 8.47, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  25. Lee, C.-G., and Hurwitz, J. (1992) J. Biol. Chem. 267, 4398-4407 [Abstract/Free Full Text]
  26. Linder, P., Lasko, P. F., Ashburner, M., Leroy, P., Nielsen, P. J., Nishi, K., Schnier, J., and Slonimski, P. P. (1989) Nature 337, 121-122 [CrossRef][Medline] [Order article via Infotrieve]
  27. Wassarman, D. A., and Steitz, J. A. (1991) Nature 349, 463-464 [CrossRef][Medline] [Order article via Infotrieve]
  28. Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1989) Nucleic Acids Res. 17, 4713-4730 [Abstract]
  29. Bork, P., and Koonin, E. V. (1993) Nucleic Acids Res. 21, 751-752 [Medline] [Order article via Infotrieve]
  30. Lohman, T. M. (1993) J. Biol. Chem. 268, 2269-2272 [Abstract/Free Full Text]
  31. Pause, A., Methot, N., and Sonenberg, N. (1993) Mol. Cell. Biol. 13, 6789-6798 [Abstract]
  32. Fernandez, A., Lain, S., and Garcia, J. A. (1995) Nucleic Acids Res. 23, 1327-1332 [Abstract]
  33. Li, J., and Broyles, S. S. (1995) Nucleic Acids Res. 23, 1590-1596 [Abstract]
  34. Ono, Y., Ohno, M., and Shimura, Y. (1994) Mol. Cell. Biol. 14, 7611-7620 [Abstract]
  35. Sukegawa, J., and Blobel, G. (1995) J. Biol. Chem. 270, 15702-15706 [Abstract/Free Full Text]
  36. Company, M., Arenas, J., and Abelson, J. (1991) Nature 349, 487-493 [CrossRef][Medline] [Order article via Infotrieve]
  37. Kim, U., Garner, T. L., Sanford, T., Speicher, D., Murray, J. M., and Nishikura, K. (1994) J. Biol. Chem. 269, 13480-13489 [Abstract/Free Full Text]
  38. Ho, C. K., and Shuman, S. (1996) Virology 217, 272-284 [CrossRef][Medline] [Order article via Infotrieve]
  39. Ghisolfi, L., Joseph, G., Amalric, F., and Erard, M. (1992) J. Biol. Chem. 267, 2955-2959 [Abstract/Free Full Text]
  40. Tuteja, N., Huang, N. W., Skopac, D., Tuteja, R., Hrvatic, S., Zhang, J., Pongor, S., Joseph, G., Faucher, C., Amalric, F., and Falaschi, A. (1995) Gene (Amst.) 160, 143-148 [CrossRef][Medline] [Order article via Infotrieve]
  41. Fackelmayer, F. O., Dahm, K., Renz, A., Ramsperger, U., and Richter, A. (1994) Eur. J. Biochem 221, 749-757 [Abstract]
  42. von Kries, J. P., Buck, F., and Strätling, W. H. (1994) Nucleic Acids Res. 22, 1215-1220 [Abstract]
  43. Bode, J., Kohwi, Y., Dickinson, L., Joh, T., Klehr, D., Mielke, C., and Kohwi-Shigematsu, T. (1992) Science 255, 195-197 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.